Professor Julia Potter


Fisher AA, Southcott EN, Goh SL, Srikusalanukul W, Hickman PE, Davis MW, et al. Elevated serum cardiac troponin I in older patients with hip fracture: incidence and prognostic significance. Arch Orthop Trauma Surg. 2008 Jan 12.

Rathmalgoda C, Potter JM, Lueck CJ. Serum sodium valproate testing: is it appropriate? Med J Aust. 2007 Nov 19;187(10):582-4.

Telford RD, Bass SL, Budge MM, Byrne DG, Carlson JS, Coles D, et al. The lifestyle of our kids (LOOK) project: Outline of methods. J Sci Med Sport. 2007 Oct 8.

Fisher AA, Southcott EK, Srikusalanukul W, Davis MW, Hickman PE, Potter JM, et al. Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures. Ann Clin Lab Sci. 2007 Summer;37(3):222-32.

Newsome S, Chen K, Hoang J, Wilson JD, Potter JM, Hickman PE. Cushing's syndrome in a clinic population with diabetes. Intern Med J. 2008 Mar;38(3):178-82.

Hickman PE, Koerbin G, Southcott E, Tate J, Dimeski G, Carter A, et al. Newer cardiac troponin I assays have similar performance to troponin T in patients with end-stage renal disease. Ann Clin Biochem. 2007 May;44(Pt 3):285-9.

Arab HA, Cheung K, Hickman PE, Potter JM, Kadkhodaee M, Roberts MS. Effects of hypoxia/reperfusion injury on drug disposition in the rat isolated perfused liver. Clin Exp Pharmacol Physiol. 2007 Apr;34(4):332-8.

Roberts DM, Southcott E, Potter JM, Roberts MS, Eddleston M, Buckley NA. Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow Oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal. Ther Drug Monit. 2006 Dec;28(6):784-92.

Koerbin G, Tate JR, Potter JM, Hickman PE. The comparative analytical performance of four troponin I assays at low concentration. Ann Clin Biochem. 2005 Jan;42(Pt 1):19-23.

Parsonage WA, Galbraith AJ, Koerbin GL, Potter JM. Value of B-type natriuretic peptide for identifying significantly elevated pulmonary artery wedge pressure in patients treated for established chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2005 Apr 1;95(7):883-5.

Hickman PE, Miller E, Koerbin G, Potter JM. Changes in troponin kits preclude meaningful collection of data on population 99th percentiles. Ann Clin Biochem. 2004 Nov;41(Pt 6):503-4.

Reinders J, Parsonage W, Lange D, Potter JM, Plever S. Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service. Aust N Z J Psychiatry. 2004 Nov-Dec;38(11-12):915-22.

Greer RM, Buntain HM, Lewindon PJ, Wainwright CE, Potter JM, Wong JC, et al. Vitamin A levels in patients with CF are influenced by the inflammatory response. J Cyst Fibros. 2004 Aug;3(3):143-9.

Potter JM, McWhinney BC, Sampson L, Hickman PE. Area-under-the-curve monitoring of prednisolone for dose optimization in a stable renal transplant population. Ther Drug Monit. 2004 Aug;26(4):408-14.

Buntain HM, Greer RM, Schluter PJ, Wong JC, Batch JA, Potter JM, et al. Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax. 2004 Feb;59(2):149-55.

Greer RM, Buntain HM, Potter JM, Wainwright CE, Wong JC, O'Rourke PK, et al. Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls. Osteoporos Int. 2003 Jun;14(5):404-11.